Moderna Q2 FY2022 Earnings Report Preview: What to Look For

Analysts estimate EPS of $4.55 vs. $6.46 in Q2 FY 2021.
Revenue is expected to grow at a slower rate as global pandemic eases.
On July 29, Moderna received a U.S. government order for 66 million doses of its vaccine, with option to buy 234 million more doses.